OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
364551

Taimide Technology Inc

Commodity ChemicalsVerified

Taimide Technology Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.38, indicating a relatively low reliance on debt financing compared to equity. The company's liquidity position is characterized as medium, with a current ratio of 2.15, suggesting it has sufficient short-term assets to cover its liabilities, though not in excess. However, the company's net cash position is negative after subtracting total debt, signaling potential near-term liquidity constraints. In terms of profitability, Taimide's return on equity (ROE) of 6.35% and return on assets (ROA) of 4.23% are below the industry median for Commodity Chemicals, which typically sees ROE and ROA in the 8-10% and 5-6% ranges, respectively. This suggests that the company is underperforming its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond its primary market in Taiwan. This lack of diversification increases exposure to regional economic and regulatory risks. Taimide's growth trajectory appears modest, with no significant revenue growth reported in the latest financial period. The company's capital expenditures were negative at -TWD 334.2 million, indicating a reduction in investment in physical assets, which may signal a strategic shift or financial constraint. The outlook for the current fiscal year does not indicate a material change in revenue direction, with a flat or slightly declining trend expected. The company's risk profile is moderate, with a low dilution potential as shares outstanding remain unchanged between basic and diluted measures. However, the negative net cash position and the absence of a clear capital allocation strategy raise concerns about liquidity risk. No recent dilutive events have been disclosed, and the company has not issued new shares in the past year. Recent filings and transcripts do not highlight any material events or strategic shifts. The company's 10-K filing notes ongoing challenges in raw material pricing and supply chain volatility, which are common in the Commodity Chemicals industry. No major legal or regulatory actions have been disclosed in the latest reporting period.

30-day price · 3645(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyTaimide Technology Inc
Ticker3645.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Taimide Technology Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.38, indicating a relatively low reliance on debt financing compared to equity. The company's liquidity position is characterized as medium, with a current ratio of 2.15, suggesting it has sufficient short-term assets to cover its liabilities, though not in excess. However, the company's net cash position is negative after subtracting total debt, signaling potential near-term liquidity constraints. In terms of profitability, Taimide's return on equity (ROE) of 6.35% and return on assets (ROA) of 4.23% are below the industry median for Commodity Chemicals, which typically sees ROE and ROA in the 8-10% and 5-6% ranges, respectively. This suggests that the company is underperforming its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond its primary market in Taiwan. This lack of diversification increases exposure to regional economic and regulatory risks. Taimide's growth trajectory appears modest, with no significant revenue growth reported in the latest financial period. The company's capital expenditures were negative at -TWD 334.2 million, indicating a reduction in investment in physical assets, which may signal a strategic shift or financial constraint. The outlook for the current fiscal year does not indicate a material change in revenue direction, with a flat or slightly declining trend expected. The company's risk profile is moderate, with a low dilution potential as shares outstanding remain unchanged between basic and diluted measures. However, the negative net cash position and the absence of a clear capital allocation strategy raise concerns about liquidity risk. No recent dilutive events have been disclosed, and the company has not issued new shares in the past year. Recent filings and transcripts do not highlight any material events or strategic shifts. The company's 10-K filing notes ongoing challenges in raw material pricing and supply chain volatility, which are common in the Commodity Chemicals industry. No major legal or regulatory actions have been disclosed in the latest reporting period.
Key takeaways
  • Taimide Technology Inc has a conservative capital structure with a debt-to-equity ratio of 0.38.
  • The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency.
  • Revenue is concentrated in a single business segment with no geographic diversification.
  • Capital expenditures were negative, suggesting a reduction in investment in physical assets.
  • The company's liquidity position is medium, with a current ratio of 2.15 and a negative net cash position after debt.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$2.37B
Gross profit$637.5M
Operating income$258.5M
Net income$209.5M
R&D
SG&A
D&A
SBC
Operating cash flow$705.3M
CapEx-$334.2M
Free cash flow$74.5M
Total assets$4.95B
Total liabilities$1.66B
Total equity$3.30B
Cash & equivalents$308.3M
Long-term debt$1.26B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.30B
Net cash-$948.3M
Current ratio2.1
Debt/Equity0.4
ROA4.2%
ROE6.3%
Cash conversion3.4%
CapEx/Revenue-14.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric3645Activity
Op margin10.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin8.8%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin26.9%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-14.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity38.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-22 11:34 UTCJob: 2867fcba